MeSH term
Frequency | Condition_Probility | Aged | 5 | 0.0 |
Humans | 61 | 0.0 |
Time Factors | 3 | 0.0 |
English Abstract | 3 | 0.0 |
Female | 11 | 0.0 |
Male | 5 | 0.0 |
Middle Aged | 3 | 0.0 |
Animals | 34 | 0.0 |
Antigens, CD/*metabolism | 6 | 0.0 |
COS Cells | 8 | 0.0 |
Cercopithecus aethiops | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 4 | 0.0 |
Membrane Glycoproteins/*metabolism | 5 | 1.0 |
Mice | 16 | 0.0 |
Mitogen-Activated Protein Kinases/*metabolism | 2 | 0.0 |
Rats | 11 | 0.0 |
Receptor, Ciliary Neurotrophic Factor/genetics/*metabolism | 2 | 100.0 |
Receptors, Cytokine/*metabolism | 9 | 10.0 |
Research Support, Non-U.S. Gov't | 46 | 0.0 |
Trans-Activators/*metabolism | 4 | 0.0 |
Transfection | 8 | 0.0 |
Tumor Cells, Cultured | 18 | 0.0 |
Amino Acid Sequence | 10 | 0.0 |
Base Sequence | 11 | 0.0 |
Cell Line | 14 | 0.0 |
Cytokines/*metabolism | 2 | 0.0 |
DNA Primers | 7 | 0.0 |
Flow Cytometry | 3 | 0.0 |
Molecular Sequence Data | 14 | 0.0 |
Phosphorylation | 11 | 0.0 |
Receptor, Ciliary Neurotrophic Factor/*metabolism | 2 | 100.0 |
Signal Transduction | 10 | 0.0 |
Cytokines/pharmacology | 2 | 0.0 |
Growth Inhibitors/pharmacology | 3 | 2.0 |
Interleukin-6/pharmacology | 3 | 1.0 |
Lymphokines/pharmacology | 4 | 2.0 |
Macromolecular Substances | 8 | 0.0 |
Protein Binding/physiology | 2 | 0.0 |
Receptors, Cytokine/genetics/*metabolism | 2 | 6.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Binding Sites | 8 | 0.0 |
Cell Division/drug effects | 5 | 0.0 |
*Interleukin-6 | 22 | 6.0 |
Ligands | 3 | 0.0 |
Protein Structure, Tertiary | 3 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Cell Division | 4 | 0.0 |
Adult | 6 | 0.0 |
Cells, Cultured | 7 | 0.0 |
RNA, Messenger/analysis | 3 | 0.0 |
Receptor, Ciliary Neurotrophic Factor/genetics | 2 | 33.0 |
Tumor Necrosis Factor-alpha/pharmacology | 2 | 0.0 |
3T3 Cells | 2 | 0.0 |
DNA-Binding Proteins/metabolism | 10 | 0.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Mitogen-Activated Protein Kinases/metabolism | 3 | 0.0 |
Protein-Tyrosine Kinase/metabolism | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
Signal Transduction/*physiology | 2 | 0.0 |
Trans-Activators/metabolism | 10 | 1.0 |
Transcription Factors/genetics/metabolism | 2 | 0.0 |
Receptors, Interleukin-6/metabolism | 2 | 7.0 |
Antigens, CD/physiology | 2 | 0.0 |
Blotting, Northern | 4 | 0.0 |
Comparative Study | 6 | 0.0 |
Membrane Glycoproteins/physiology | 2 | 1.0 |
Mitogen-Activated Protein Kinase 3 | 3 | 0.0 |
Receptors, Cytokine/physiology | 2 | 7.0 |
Tumor Cells, Cultured/drug effects/metabolism | 2 | 1.0 |
Protein-Tyrosine-Phosphatase/metabolism | 3 | 2.0 |
*Signal Transduction | 7 | 0.0 |
Antigens, CD/metabolism | 7 | 0.0 |
Cell Membrane/metabolism | 3 | 0.0 |
Dimerization | 5 | 0.0 |
Membrane Glycoproteins/metabolism | 7 | 1.0 |
Models, Molecular | 7 | 0.0 |
Protein Structure, Secondary | 3 | 0.0 |
Receptors, Cytokine/metabolism | 3 | 3.0 |
Signal Transduction/physiology | 2 | 0.0 |
Antigens, CD/genetics | 3 | 2.0 |
Membrane Glycoproteins/genetics | 3 | 1.0 |
Receptors, Cytokine/genetics | 3 | 9.0 |
Recombinant Proteins/pharmacology | 2 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 3 | 0.0 |
*Milk Proteins | 3 | 0.0 |
Peptides/*pharmacology | 2 | 0.0 |
Protein-Tyrosine Kinase/*metabolism | 2 | 0.0 |
Proteins/metabolism | 2 | 0.0 |
*Proto-Oncogene Proteins | 2 | 0.0 |
Tyrosine/metabolism | 3 | 0.0 |
Growth Inhibitors/*analysis | 2 | 15.0 |
Immunohistochemistry | 4 | 0.0 |
Lymphokines/*analysis | 2 | 1.0 |
Pregnancy | 4 | 0.0 |
Pregnancy, Animal/*metabolism | 2 | 13.0 |
Receptors, Cytokine/*analysis | 2 | 12.0 |
Tissue Distribution | 2 | 0.0 |
Interleukin-1/pharmacology | 2 | 0.0 |
Kinetics | 3 | 0.0 |
Corticotropin/secretion | 2 | 3.0 |
Pro-Opiomelanocortin/genetics | 2 | 11.0 |
Blotting, Western | 2 | 0.0 |
Growth Inhibitors/*metabolism | 6 | 10.0 |
Interleukin-6/metabolism | 3 | 1.0 |
*Lymphokines | 9 | 20.0 |
Protein Binding | 7 | 0.0 |
*Growth Inhibitors | 13 | 23.0 |
Blotting, Southern | 2 | 0.0 |
Ciliary Neurotrophic Factor | 8 | 6.0 |
Lymphokines/*metabolism | 8 | 1.0 |
Protein Conformation | 3 | 0.0 |
Lymphokines/metabolism | 3 | 1.0 |
Receptors, Cytokine/chemistry/*metabolism | 2 | 33.0 |
Binding, Competitive | 2 | 0.0 |
Point Mutation | 2 | 0.0 |
Structure-Activity Relationship | 2 | 0.0 |
Binding Sites/genetics | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Receptors, Cytokine/*genetics | 4 | 7.0 |
Antigens, CD/*chemistry | 2 | 7.0 |
Electrostatics | 2 | 1.0 |
Membrane Glycoproteins/*chemistry | 2 | 6.0 |
*Chromosomes, Human, Pair 5 | 2 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Placenta/metabolism | 2 | 1.0 |
Transcription, Genetic | 2 | 0.0 |
Solubility | 2 | 0.0 |
Cytoplasm/metabolism | 2 | 0.0 |
Membrane Glycoproteins/*physiology | 2 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Interleukin-11/physiology | 2 | 50.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Mutation | 2 | 0.0 |
Receptor, Ciliary Neurotrophic Factor | 4 | 4.0 |
*Gene Expression | 2 | 0.0 |
Liver/metabolism | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Gene Expression | 2 | 0.0 |
Nerve Tissue Proteins/*metabolism | 2 | 0.0 |
*Antigens, CD | 2 | 0.0 |
Peptide Library | 2 | 1.0 |
Nuclear Magnetic Resonance, Biomolecular | 2 | 1.0 |
*Repressor Proteins | 2 | 0.0 |
*Transcription Factors | 2 | 0.0 |
